# LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers

> **NCT00240526** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 79 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Engerix™ -B
- **BIOLOGICAL:** Hepatitis B immunoglobulin (HBIg)

## Key facts

- **NCT ID:** NCT00240526
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2016-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240526, "LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00240526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*